Diabetes drug is called heart attack risk

Published July 16, 2010

Diabetes drug is called heart attack risk
GAITHERSBURG, Md. • Avandia, a controversial diabetes drug, should be withdrawn from the market or see its sales severely restricted because it increases the risks of heart attacks, a federal medica
Read more on St. Louis Post-Dispatch

Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma
Aeterna Zentaris Inc. , a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc. , has been granted orphan-drug designation by the U.S.
Read more on PR Newswire via Yahoo! Finance